eprintid: 10188569
rev_number: 12
eprint_status: archive
userid: 699
dir: disk0/10/18/85/69
datestamp: 2024-03-07 16:12:35
lastmod: 2024-10-01 14:31:06
status_changed: 2024-03-07 16:12:35
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Hurst, John R
creators_name: Gale, Chris P
creators_name: Global Working Group, on Cardiopulmonary Risk
title: MACE in COPD: addressing cardiopulmonary risk
ispublished: pub
divisions: UCL
divisions: B02
divisions: C10
divisions: D17
divisions: K71
note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
date: 2024-05
date_type: published
publisher: Elsevier BV
official_url: http://dx.doi.org/10.1016/s2213-2600(24)00038-9
oa_status: green
full_text_type: other
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 2254538
doi: 10.1016/S2213-2600(24)00038-9
medium: Print-Electronic
pii: S2213-2600(24)00038-9
lyricists_name: Hurst, John
lyricists_id: JHURS15
actors_name: Hurst, John
actors_id: JHURS15
actors_role: owner
full_text_status: public
publication: The Lancet Respiratory Medicine
volume: 12
number: 5
pagerange: 345-348
event_location: England
citation:        Hurst, John R;    Gale, Chris P;    Global Working Group, on Cardiopulmonary Risk;      (2024)    MACE in COPD: addressing cardiopulmonary risk.                   The Lancet Respiratory Medicine , 12  (5)   pp. 345-348.    10.1016/S2213-2600(24)00038-9 <https://doi.org/10.1016/S2213-2600%2824%2900038-9>.       Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10188569/2/Hurst_MACE%20in%20COPD_AAM.pdf